These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21569455)
41. VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. Nygren I; Larsson A; Johansson A; Askmark H Neuroreport; 2002 Dec; 13(17):2199-201. PubMed ID: 12488796 [TBL] [Abstract][Full Text] [Related]
42. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis. Liu J; Gao L; Zang D PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465 [TBL] [Abstract][Full Text] [Related]
43. CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis. Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252 [TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Iłzecka J; Stelmasiak Z; Dobosz B Cytokine; 2002 Dec; 20(5):239-43. PubMed ID: 12550109 [TBL] [Abstract][Full Text] [Related]
47. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. Fialová L; Svarcová J; Bartos A; Ridzon P; Malbohan I; Keller O; Rusina R Eur J Neurol; 2010 Apr; 17(4):562-6. PubMed ID: 19968709 [TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis. Suzuki M; Watanabe T; Mikami H; Nomura M; Yamazaki T; Irie T; Ishikawa H; Yasui K; Ono S J Neurol Sci; 2009 Oct; 285(1-2):125-9. PubMed ID: 19592043 [TBL] [Abstract][Full Text] [Related]
49. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350 [TBL] [Abstract][Full Text] [Related]
50. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis. Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057 [TBL] [Abstract][Full Text] [Related]
52. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650 [TBL] [Abstract][Full Text] [Related]
53. Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Süssmuth SD; Tumani H; Ecker D; Ludolph AC Neurosci Lett; 2003 Dec; 353(1):57-60. PubMed ID: 14642437 [TBL] [Abstract][Full Text] [Related]
56. Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis. Lehnert S; Costa J; de Carvalho M; Kirby J; Kuzma-Kozakiewicz M; Morelli C; Robberecht W; Shaw P; Silani V; Steinacker P; Tumani H; Van Damme P; Ludolph A; Otto M Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):344-50. PubMed ID: 24575871 [TBL] [Abstract][Full Text] [Related]